« Back to Record
Citation APA

Marinello, A., Rotow, J. J., Lomibao, M., Leporati, R., Feng, J., Metro, G., Brandão, M., Nassar, A. A., Citarella, F., Planchard, D., Mezquita, L., Besse, B., Drilon, A., & Aldea, M. (2025). Rechallenge with first-generation RET inhibitors in RET-rearranged NSCLC pre-treated with selpercatinib or pralsetinib: Results from the RET MAP registry. Journal of clinical oncology : official journal of the American Society of Clinical Oncology., 43, 8646(2025).


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/401652

Marinello, A., Rotow, J. J., Lomibao, M., Leporati, R., Feng, J., Metro, G., Brandão, M., Nassar, A. A., Citarella, F., Planchard, D., Mezquita, L., Besse, B., Drilon, A., & Aldea, M. (2025). Rechallenge with first-generation RET inhibitors in RET-rearranged NSCLC pre-treated with selpercatinib or pralsetinib: Results from the RET MAP registry. Journal of clinical oncology : official journal of the American Society of Clinical Oncology., 43, 8646(2025).